133 related articles for article (PubMed ID: 2988736)
41. [Massive bone allografts in large bone defects after tumor surgery: a clinical long-term study].
Shinohara N; Yokoyama K; Chuman H
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1820-6. PubMed ID: 2543324
[TBL] [Abstract][Full Text] [Related]
42. [Pulmonary malignant fibrous histiocytoma presenting as hemothorax].
Hachiya T; Okada K; Yamazaki Y; Hayasaka M; Yoshikawa S; Kubo K; Sekiguchi M; Honda T; Hanyuuda M
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar; 34(3):336-40. PubMed ID: 8778476
[TBL] [Abstract][Full Text] [Related]
43. Primary malignant fibrous histiocytoma of the left atrium. Surgical and chemotherapeutic management.
Eckstein R; Gössner W; Rienmüller R
Br Heart J; 1984 Sep; 52(3):354-7. PubMed ID: 6087863
[TBL] [Abstract][Full Text] [Related]
44. Control of primary osteosarcoma with chemotherapy.
Jaffe N; Robertson R; Takaue Y; Cangir A; Wallace S; Carrasco H; Eftekhari F; Ayala A; Wang A
Cancer; 1985 Aug; 56(3):461-6. PubMed ID: 3873985
[TBL] [Abstract][Full Text] [Related]
45. Osteosarcoma of the limb: an institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery.
Postma A; Kamps WA; Schraffordt Koops H; Veth RP; Göeken LN; Molenaar WM
Cancer Treat Res; 1993; 62():361-4. PubMed ID: 7682095
[No Abstract] [Full Text] [Related]
46. [Long-term survival of malignant fibrous histiocytoma of the chest wall by multidisciplinary treatment].
Kitazono I; Saigenji H
Kyobu Geka; 2007 Mar; 60(3):221-4. PubMed ID: 17352141
[TBL] [Abstract][Full Text] [Related]
47. Inflammatory fibrous histiocytoma: response to non-surgical therapy: a case report.
Smith DK; Poon MC; Flint A
Med Pediatr Oncol; 1979; 7(3):263-7. PubMed ID: 232240
[TBL] [Abstract][Full Text] [Related]
48. Intra-arterial chemotherapy of malignant fibrous histiocytoma of the pelvis.
Shuman LS; Chuang VP; Wallace S; Benjamin RS; Murray J
Radiology; 1982 Feb; 142(2):343-6. PubMed ID: 6275453
[TBL] [Abstract][Full Text] [Related]
49. Malignant fibrous histiocytoma of soft tissue in childhood.
Raney RB; Allen A; O'Neill J; Handler SD; Uri A; Littman P
Cancer; 1986 Jun; 57(11):2198-201. PubMed ID: 3008978
[TBL] [Abstract][Full Text] [Related]
50. [Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].
Boussen H; Mezzi F; Gamoudi A; Daldoul O; Ben Hamida H; Mezlini A; Khalfallah S; Karray S; Ben Romdhane K; Ben Ghachem M; Ben Abdallah M; Douik M; Saadi A; Ben Ayed F; Ben Hassine H
Bull Cancer; 2000 Feb; 87(2):183-8. PubMed ID: 10705289
[TBL] [Abstract][Full Text] [Related]
51. [Retroperitoneal giant malignant fibrous histiocytoma: report of a case].
Kuroda H; Kishimoto T; Yasunaga Y; Takatera H; Fujioka H; Kosugi K; Tsujimoto M
Hinyokika Kiyo; 1992 Oct; 38(10):1143-6. PubMed ID: 1336304
[TBL] [Abstract][Full Text] [Related]
52. Prolonged remission of metastatic malignant fibrous histiocytoma induced by combination chemotherapy.
Clamon GH; Robinson RA; Olberding EB
J Surg Oncol; 1984 Jun; 26(2):113-4. PubMed ID: 6330457
[TBL] [Abstract][Full Text] [Related]
53. A monocentric therapy study: an approach to optimize the results of the treatment of osteosarcoma by protocols based upon HDMTX, associated with systematic conservative surgery.
Delepine N; Delepine G; Desbois JC
Cancer Treat Res; 1993; 62():327-32. PubMed ID: 7682092
[No Abstract] [Full Text] [Related]
54. Outcome of flat bone sarcomas (other than Ewing's) in children and adolescents: a study of 25 cases.
Minard-Colin V; Kalifa C; Guinebretiere JM; Brugieres L; Dubousset J; Habrand JL; Vassal G; Hartmann O
Br J Cancer; 2004 Feb; 90(3):613-9. PubMed ID: 14760373
[TBL] [Abstract][Full Text] [Related]
55. [Clinical evaluation on the sensitivity test for anti-cancer agents in malignant bone and soft-tissue tumors].
Takeuchi S; Akahoshi Y; Kasai C; Nishimoto Y
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1113-22. PubMed ID: 6088833
[TBL] [Abstract][Full Text] [Related]
56. Osteosarcoma: experience with the Rosen T10 protocol at RCH, Melbourne.
Ekert H; Tiedemann K
Cancer Treat Res; 1993; 62():355-9. PubMed ID: 7682094
[No Abstract] [Full Text] [Related]
57. [Neoadjuvant chemotherapy in malignant fibrous histiocytoma of the limbs: 10 years of experience (1983-1992) at the Rizzoli Orthopedic Institute].
Bacci G; Ferrari S; Picci P; Forni C; Donati D; Manfrini M; Baldini N; Iantorno D; Campanacci M
Minerva Med; 1996 Apr; 87(4):135-46. PubMed ID: 8700337
[TBL] [Abstract][Full Text] [Related]
58. [Alternative chemotherapy of malignant bone neoplasms in children].
Jurczyk-Procyk S; Perek D
Probl Med Wieku Rozwoj; 1990; 16():55-68. PubMed ID: 1726893
[TBL] [Abstract][Full Text] [Related]
59. Malignant fibrous histiocytoma of the patella.
Roger DJ; Uhl RL; Carl A
Orthopedics; 1994 Feb; 17(2):189-92. PubMed ID: 8190684
[No Abstract] [Full Text] [Related]
60. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
